Search

Objective To investigate the mechanism and the effect of miR-524-5p regulating HEG1 expression on the proliferation and epithelial-mesenchymal transition of esophageal cancer cells. Methods The expression levels of miR-524-5p and HEG1 mRNA in esophageal cancer cells and normal esophageal epithelial cells were detected by qRT-PCR. KYSE30 cells were divided into miR-524-5p mimic group, miR-524-5p NC group, miR-524-5p mimic+pcDNA3.1 group, and miR-524-5p mimic+pcDNA3.1-HEG1 group. Non-transfected cells were set as the normal control group (group Control). CCK-8 method was applied to detect the proliferation ability of KYSE30 cells. Western blot analysis was conducted to detect the expression of proteins related to EMT, invasion, and migration and the HEG1 protein. Scratch and Transwell assays were applied to detect the migration and invasion abilities of KYSE30 cells. A dual-luciferase reporter gene was used to examine the targeting relationship between miR-524-5p and HEG1. Results miR-524-5p was lowly expressed in four esophageal cancer cell lines, namely, TE-1, KYSE30, KYSE150, and NEC (P < 0.05). KYSE30 cells with the lowest expression level were selected for subsequent experiments. HEG1 mRNA was highly expressed in four esophageal cancer cell lines (P < 0.05). The GEPIA database showed that HEG1 was highly expressed in esophageal cancer tumor tissues (P < 0.05). KYSE30 cells in the miR-524-5p mimic group had lower proliferation ability, colony formation number, mesenchymal marker protein expression, and migration and invasion abilities and upregulated epithelial marker protein E-cadherin level than cells in the miR-524-5p NC group (P < 0.05). The miR-524-5p mimic+pcDNA3.1-HEG1 group significantly reversed the inhibitory effect of overexpression of miR-524-5p on the proliferation, epithelial–mesenchymal transformation, invasion, and metastasis of KYSE30 cells (P < 0.05). The luciferase activity of cells in the miR-524-5p mimic and WT-HEG1 co-transfection groups was lower than that in the miR-524-5p NC and WT-HEG1 co-transfection groups (P < 0.05). Conclusion miR-524-5p is lowly expressed in EC cells and tissues. The overexpression of miR-524-5p can negatively regulate the expression of HEG1 in esophageal cancer cell line (KYSE30 cells) and reduce the proliferation, EMT process, and invasion and migration abilities of KYSE30 cells.

Non-thermal processing technology has been widely used in starch modification because of its advantages such as environmental friendliness, safety and high efficiency. After non-thermal modification, changes in the granular morphology, crystal shape, crystallinity and helical structure of starch will affect its gelatinization and retrogradation characteristics, solubility and digestibility. Changes in functional characteristics can further improve the practical application of starch. In this paper, the principles of six non-thermal processing technologies for starch modification, namely, ball milling, pulse electric field, high pressure, ultrasound, radiation and plasma are reviewed, the importance of non-thermal technology for starch granule structure as well as the effect of starch structural changes at different levels on its functional properties are discussed, and future prospects for the application of non-thermal technology in starch deep processing are proposed.

A numerical analysis of a compact microring resonator that was defined on a yttrium-aluminum-garnet (YAG) thin film bonded on top of a SiO2 cladding layer and operated at the wavelengths of approximately 1.064 and 1.6 μm was performed. The single-mode conditions of YAG waveguides at different waveguide geometries and their propagation losses at different SiO2 cladding layer thicknesses were systematically analyzed. The key design parameters of the microring resonator, such as gap size and ring radius, were simulated based on the 2.5-dimensional variational finite-difference time-domain method. This study could be helpful in understanding the mechanism of microring resonators defined on YAG thin films and fabricating integrated microlaser sources on YAG-on-insulators.

Objective To assess the safety and feasibility of incision in the retroauricular sulcus for removal of benign tumors in the lower pole of the parotid gland and to provide some ideas for aesthetic consideration of parotidectomy. Methods In total, 18 cases with benign tumors of the lower pole regions of the parotid gland were included in this study, including 9 pleomorphic adenomas, 2 myoepitheliomas, 5 Warthin tumors, 1 basal cell adenoma and 1 oncocytoma. Three months after the operation, facial paralysis and salivary fistula were assessed. A visual analog scale was used to score the cosmetic satisfaction of the surgical incision. Tumor recurrence was followed up 6 ~ 12 months after operation. Results In 18 patients with benign tumors the lower pole regions of the parotid gland, the tumor diameter ranges from 1.0 to 3.1 cm, with an average value of 2.5 cm. All patients experienced successful complete removal of the parotid mass with the minimally invasive retroauricular approach, and all wounds healed in one stage after operation. No serious complications, such as permanent facial paralysis and tumor recurrence, occurred 3 months after the operation. The patients were satisfied with the appearance of the surgical incision (aesthetic score 9.3 ± 0.4), achieving the expected aesthetic effect. Conclusion This approach is feasible and safe for most small benign parotid tumors located in the lower pole region of the parotid gland and in the posterior region of the jaw. The scar is located in the retroauricular sulcus, which significantly meets the aesthetic needs of the concealed incision for patients.

Objective To study the clinical manifestations and biological characteristics of Stafne bone cavity and to reduce misdiagnosis and excessive treatment. Methods Four cases of typical Stafne bone cavity, including clinical features and follow ⁃ up data, were retrospectively analyzed, and the results, combined with a review of the literature, were analyzed in terms of the etiology, clinical manifestations, diagnostic criteria and treatment of Stafne bone cavity. Results Stafne bone cavity is also known as static bone cavity, idiopathic bone cavity, latent bone cavity defects, aber⁃ rant salivary glands, heterotopic mandibular salivary glands, mandibular lingual bone cavity, mandibular lingual cortical bone defect, etc. The incidence of Stafne bone cavity is approximately 0.5%. This condition is easily misdiagnosed as a jaw or jaw cyst tumor and treated unnecessarily. Most scholars believe that the causes of Stafne bone cavity can be di⁃ vided into two types: developmental and glandular. Stafne bone cavity is characterized by either no symptoms or occa⁃ sional pain. This condition is observed mostly in 40⁃60⁃year⁃old male patients. The imaging diagnostic criteria for Stafne bone cavity are as follows: ① projecting round or ovoid mandible and uniform density with a distinct bone⁃cortical white line; ② clearly distinguishable from adjacent structures, such as teeth; ③ typical location in the mandibular angle and molar area, below the mandibular neural tube. Most Stafne bone cavities without advanced bone destruction do not re⁃ quire treatment, although individual cases may gradually progress. Conclusion Stafne bone cavity presents no symp⁃ toms or causes occasional pain and can be clearly diagnosed with CBCT. This condition does not require surgical treat⁃ ment and should be followed up with observation.